Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Lancet Infect Dis. 2011 Aug;11(8):622-32. doi: 10.1016/S1473-3099(11)70147-5.

    The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.

    Source

    Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA. ejentes@cdc.gov

    Erratum in

    • Lancet Infect Dis. 2012 Feb;12(2):98.

    Abstract

    The changing epidemiology of yellow fever and continued reports of rare but serious adverse events associated with yellow fever vaccine have drawn attention to the need to revisit criteria for the designation of areas with risk for yellow fever virus activity, and to revise the vaccine recommendations for international travel. WHO convened a working group of international experts to review factors important for the transmission of yellow fever virus and country-specific yellow fever information, to establish criteria for additions to or removal from the list of countries with risk for yellow fever virus transmission, to update yellow fever risk maps, and to revise the recommendations for vaccination for international travel. This report details the recommendations made by the working group about criteria for the designation of risk and specific changes to the classification of areas with risk for transmission of yellow fever virus.

    Copyright © 2011 Elsevier Ltd. All rights reserved.

    Comment in

    • One decade on. [Lancet Infect Dis. 2011]
    PMID:
    21798462
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk